Observational study / 2013
Long-term exposure to low to moderate arsenic levels was linked to increased incidence and mortality of cardiovascular disease.
Researchers evaluated 3575 American Indian participants from the Strong Heart Study followed from 1989-1991 through 2008, using baseline urinary arsenic species as a biomarker of long-term exposure. Over follow-up, 1184 participants developed fatal or nonfatal cardiovascular disease. Comparing the highest to lowest quartiles of arsenic (>15.7 vs. <5.8 μg/g creatinine), adjusted hazard ratios were 1.65 (95% CI, 1.20 to 2.27) for CVD mortality and 1.32 (95% CI, 1.09 to 1.59) for incident CVD. Corresponding hazard ratios were 1.71 for coronary heart disease mortality and 1.30 for incident CHD; associations varied by region and attenuated after adjustment for diabetes, hypertension, and kidney disease. A stated limitation was the lack of direct measurement of individual arsenic levels in drinking water.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 3575 American Indian men and women aged 45 to 74 years
- What was measured
- Incident fatal and nonfatal cardiovascular disease, coronary heart disease, and stroke
THE PAPER
Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study.
Moon KA, Guallar E, Umans JG, Devereux RB, Best LG, Francesconi KA, Goessler W, Pollak J, Silbergeld EK, Howard BV, Navas-Acien A. Ann Intern Med, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.